Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Arrayit Corporation claimed to have invented a technology to test for any disease using a drop of blood, including Covid-19 and cancer. By Remy Tumin A biotech executive in California was convicted on ...

OXFORD, England--(BUSINESS WIRE)-- Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch® 3D ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) announced it has obtained clearance from the Ministry of Health, Labour and Welfare (MHLW) in Japan for the GenetiSure Dx ...

Colorectal cancer (CRC) is one of the most malignant cancers with high morbidity and mortality. MicroRNAs (miRNAs) are small non-coding RNAs that affect biological processes by binding to mRNAs and ...

1 Department of Cardiology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China 2 Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology, Guangzhou, China ...

Abdominal aortic aneurysms (AAAs) are highly lethal diseases without effective clinical predictors and therapeutic targets. Vascular microcalcification, as detected by fluorine-18-sodium fluoride, has ...

Agilent Technologies Inc. introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research. Delivering up-to-date content for cytogenetic ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...